Selman Renee 4

4 · AGILE THERAPEUTICS INC · Filed Jan 26, 2018

Form 4

Period: 2018-01-24

Chief Commercial Officer

Transactions

Tax Payment
Common Stock
2018-01-25$3.32/sh−6,455$21,431→ 71,628 total
Award
Employee Stock Options (Right to Buy)
2018-01-24+107,000→ 107,000 total
Exercise: $3.46Exp: 2028-01-23→ Common Stock (107,000 underlying)
Award
Restricted Stock Units
2018-01-24+13,200→ 48,200 total
→ Common Stock (13,200 underlying)
Exercise/Conversion
Restricted Stock Units
2018-01-25+17,500→ 30,700 total
→ Common Stock (17,500 underlying)
Exercise/Conversion
Common Stock
2018-01-25+17,500→ 78,083 total

Footnotes (4)

[F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
[F2]This option was granted on January 24, 2018. 25% of the shares subject to the stock option vest on January 24, 2019, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 24, 2022.
[F3]The restricted stock units were granted on January 24, 2018 and will be fully vested and delivered on January 24, 2019.
[F4]The restricted stock units were granted on January 25, 2017 and vest as follows: 17,500 units vested and were delivered on January 25, 2018, and 17,500 units will vest and be delivered on January 25, 2019.

Documents

1 file